Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s): QNTM

Healthcare

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

CSE:QNTM - Post by User

Quantum BioPharma Ltd > Things need to be address:

<< Previous

Bullboard Posts

Next >>

Comment by Mhae88on Apr 09, 2021 1:42am

27 Views

Post# 32964839

RE:RE:RE:RE:RE:Things need to be address:

For Durkacz and Saeed, founders of the original company, this was well past a disagreement on strategy or corporate direction; this was a refusal to meet the duty directors and officers of a company have towards its shareholders. As Directors themselves, Durkacz and Saeed felt obligated to take action. They requisitioned a shareholders meeting for March 31, 2021. The Bokhari group sought to postpone this meeting for at least six months.

<< Previous

Bullboard Posts

Next >>

Boeing workers end strike, return to work